Skip to main content
. 2013 May;110(5):690–701. doi: 10.1093/bja/aet068

Table 3.

Summary of randomized controlled trials evaluating cancer recurrence in patients who underwent colon cancer surgery with or without perioperative transfusions. CI, confidence interval

Year First author Sample size Odds ratio [95% CI] Outcome
1985 Frankish 174 1.02 [0.5, 2.06] Recurrence in 24% of both transfused and non-transfused patients
1990 Cheslyn-Curtis 961 1.16 [0.88, 1.52] Local recurrence or distal metastasis in 33 vs 36% of transfused and non-transfused patients, respectively
1990 Harder 266 1.7 [0.93, 3.10] Recurrence in 40 vs 28% of transfused and non-transfused patients, respectively
1992 Tartter 339 2.39 [1.46, 3.91] Recurrence in 40 vs 21% of transfused and non-transfused patients, respectively
1994 Heiss 100 2.1 [0.83, 5.32] Recurrence in 33 vs 19% of transfused and non-transfused patients, respectively
1994 Houbiers 697 1.23 [0.87, 174] Recurrence in 30 vs 26% of transfused and non-transfused patients, respectively
1995 Busch 420 1.9 [1.22, 296] Recurrence in 41 vs 27% of transfused and non-transfused patients, respectively